2020 Annual Meeting | C172 - Neuro-oncology in 2020: Navigating Current Trends

Date Wednesday 04/29/20

Time 07:00 AM - 09:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Maciej M. Mrugala, MD, PhD, MPH, FAAN

Topic(s) Neuro-oncology

Learning Objectives Participants should be able to identify novel developments in the field of neuro-oncology with emphasis on molecular testing, and new emerging therapies.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Event Timeline
07:00 AM - 07:05 AM	Introduction	Introduction Maciej M. Mrugala, MD, PhD, MPH, FAAN
07:05 AM - 07:45 AM	Speaker	Deciphering Molecular Testing in Neuro-oncology Seema Nagpal, MD, FAAN
07:45 AM - 08:20 AM	Speaker	Advances in Neurosurgical Treatment of Brain Tumors Daniel P. Cahill, MD, PhD
08:20 AM - 09:00 AM	Speaker	Medical Therapies in Neuro-oncology: What is New? Maciej M. Mrugala, MD, PhD, MPH, FAAN

Faculty Disclosures
Maciej M. Mrugala, MD, PhD, MPH, FAAN	Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
Seema Nagpal, MD, FAAN	Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mirati. Dr. Nagpal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiyatec. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Telix. Dr. Nagpal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Midatech.
Daniel P. Cahill, MD, PhD	Daniel P. Cahill, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Advise Connect Inspire. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for German Accelerator. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $0-$499 for serving as a Consultant for Incephalo. Daniel P. Cahill, MD, PhD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boston Scientific.

��ɫ��

��ɫ��